logo

Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance

The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *